009420.KS · 한올바이오파마

South Korea · RS rating 30 · As of 2026-10-14

Price41,750.00 KRW
1-day change-0.1%
RS rating (overall / 1M / 3M / 12M)30 / 5 / 7 / 82
StageBasing
Composite / Minervini / CANSLIM score23 / 27 / 10
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-7660.0%
Sales growth Q/Q+10.6%
Distance from 52-week high+41.0%
Market cap (USD)$1.7B
Open South Korea in the interactive screener